BCNSP common mistakes
BCNSP · Understand the traps and how to avoid them.
Calculating enteral or parenteral calorie and protein needs from actual body weight in an obese patient without applying adjusted or ideal body weight and stress/activity factors, then choosing a formula or volume from that inflated number.
Candidates memorize the Harris-Benedict or 25-30 kcal/kg shortcut and apply it uniformly, forgetting that obesity, critical illness, and burns each alter the appropriate weight reference and may require permissive underfeeding or high protein.
What to do instead
Before any calculation, classify the patient (obese, critically ill, burned, refeeding risk) and state the weight reference explicitly. Practice a fixed workflow: determine IBW or ABW, select kcal/kg range for the condition, select protein g/kg (often higher, 1.2-2.0 g/kg IBW in obesity and critical illness), then convert to formula volume or PN grams.
Ordering or advancing enteral feeding without first confirming gastric residual, tolerance, and aspiration risk, or conversely withholding feeding solely because of a single high residual in an asymptomatic patient.
Residual-volume thresholds have changed and are no longer a standalone reason to stop feeding; candidates either ignore residuals entirely or cling to outdated cutoff numbers without assessing symptoms, tube position, and aspiration risk factors.
What to do instead
Assess the whole picture: symptoms (nausea, distension, emesis), tube tip location on imaging, sedation and aspiration risk, and prokinetic use. Know that a high residual prompts evaluation and possibly a prokinetic or post-pyloric tube rather than automatic cessation, and that checking residuals is not routine in all patients.
Placing a nasoenteric or PEG tube without verifying contraindications such as coagulopathy, ascites, gastric varices, or prior abdominal surgery, or failing to confirm tip position before first use.
Access questions reward pattern recognition of relative contraindications, and candidates conflate PEG and nasoenteric contraindications or assume a tube is usable once placed.
What to do instead
Build a contraindication checklist by access type: PEG (coagulopathy, ascites, varices, morbid obesity, peritoneal carcinomatosis, inadequate window), nasoenteric (facial trauma, base of skull fracture, esophageal varices, obstruction). Always confirm position radiographically or by pH/aspirate before feeding and document it.
Selecting a specialty formula (renal, hepatic, immune-modulating, elemental) by disease label alone without checking whether its macronutrient profile actually matches the patient's needs, and ignoring that standard polymeric formula is appropriate for most patients.
Candidates associate diseases with branded formula categories and assume the label guarantees benefit, overlooking that many specialty formulas are lower in protein or higher in cost without proven outcome benefit.
What to do instead
Justify every formula choice with a specific nutrient rationale: protein content versus requirement, electrolyte limits, fiber need, digestion/absorption capacity, and cost. Default to standard polymeric formula unless a documented indication (e.g., true malabsorption, chyle leak, ARDS immune modulation) exists, and state the reason.
Compounding or ordering parenteral nutrition with incompatible additive combinations, or failing to account for calcium-phosphate precipitation, trace element stability, and lipid emulsion compatibility.
Candidates memorize individual compatibility facts but do not apply them to the whole bag, and they overlook that order of mixing, concentration, pH, and temperature determine precipitation risk.
What to do instead
Learn the compatibility framework: calcium and phosphate precipitate especially at high concentrations and in the presence of certain salts; check final concentrations against known limits, use cysteine or appropriate pH adjustment, and separate incompatible additives. Verify lipid compatibility with the aqueous phase and review the compounder's sequence.
Missing refeeding syndrome risk stratification and failing to start thiamine and electrolyte repletion before initiating nutrition in a high-risk patient.
Candidates focus on calorie prescription and forget that the first 48-72 hours carry the highest risk, and they under-recognize risk factors such as low BMI, minimal intake for days, alcohol use, and low baseline phosphate.
What to do instead
Screen every patient with a structured risk tool (NICE criteria or equivalent). For high risk, start at 10-20 kcal/kg, give thiamine before feeding, replete phosphate, potassium, and magnesium, and check electrolytes daily for the first several days with a written monitoring plan.
Ignoring the transition from parenteral to enteral or oral nutrition, continuing PN at full rate while advancing enteral feeds, or failing to taper PN as oral intake improves.
Candidates treat each modality as a separate topic and do not practice the overlap phase, where overfeeding, hyperglycemia, and line complications occur if PN is not reduced.
What to do instead
Plan the transition explicitly: estimate enteral or oral calories and protein, reduce PN proportionally as tolerance is demonstrated (commonly over 1-3 days), monitor glucose and electrolytes, and remove the central line once PN is no longer needed. Document the criteria for stopping PN.
Monitoring only weight and basic labs while omitting the nutrition-specific parameters: prealbumin trend interpretation, nitrogen balance, fluid status, and micronutrient surveillance during prolonged support.
Candidates confuse acute-phase reactants with nutrition markers and rely on a single prealbumin value, and they forget that prolonged PN or EN requires monitoring for deficiencies and toxicities.
What to do instead
Use prealbumin only as a trend with inflammation context, not a single value. Build a monitoring schedule: weekly weight and intake, electrolytes and renal function, glucose, triglycerides during lipid infusion, liver enzymes, and periodic micronutrient levels (e.g., zinc, copper, selenium, B12, vitamin D) with adjustment of the regimen.
Failing to recognize and manage central line-associated complications of PN, such as catheter-related bloodstream infection, thrombosis, or occlusion, and attributing fever in a PN patient to other causes.
Candidates know PN is delivered centrally but do not connect line care, sterile technique, and prompt evaluation of new fever or line dysfunction to the nutrition plan.
What to do instead
Treat any new fever or line dysfunction in a PN patient as possible CRBSI until proven otherwise: obtain cultures, assess the exit site, and involve the line team. Review sterile compounding and hub care, consider locking and thrombotic evaluation, and know when the line must be removed.
Applying adult nutrition thresholds and formulas to pediatric or neonatal patients, or ignoring disease-specific adjustments such as hepatic or renal formulas in organ failure without checking electrolyte and fluid limits.
Candidates study one population and one set of numbers, then reuse them across ages and conditions where fluid tolerance, protein needs, and electrolyte handling differ substantially.
What to do instead
State the population and use age-appropriate references (e.g., pediatric weight-based requirements, neonatal fluid limits). For organ failure, adjust the formula to the actual electrolyte and fluid constraints and recheck labs after any change rather than assuming the disease-specific product is automatically correct.